"In the Spotlight: LinXis technology discussed in Dutch medical oncology journal"Read more
Our platinum-based Lx® linker offers a new paradigm for the manufacturing of antibody-drug conjugates.
Like a molecular super-glue, our proprietary Lx® Linker generates an extremely strong bond between drugs and antibody. The Linker takes this strength from its platinum core. The natural ability of platinum to bind to drugs and antibodies makes for an extremely simple, efficient, and cost-effective manufacturing process.
In addition to this manufacturing advantage, the Lx® Linker confers distinct biological properties to the antibody-drug conjugates, translating into a favorable safety and efficacy profile.